Source: School Course 13



Rating:

Share or cite this content

Citations should be made in the following way:
D. Cirillo (Milan, Italy). Trials for TB infection diagnostics: designing a protocol. School Course 13

Member's Comments

No comment yet.

Related content which might interest you: Trials for TB disease diagnostics: designing a protocol Source: School Course 13 Year: 2013 Trials for TB infection and disease drugs: special aspects Source: School Course 13 Year: 2013 Trials for TB infection and disease drugs: special aspects Source: School Course 13 Year: 2013 Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019 Year: 2020 The WHO Guidelines for the Programmatic Management of drug-resistant TB: the 2011 update - recommendations and evidence Source: Annual Congress 2011 - ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project) Year: 2011 The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis Source: Breathe, 13 (3) e65; 10.1183/20734735.005517 Year: 2017 Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016 New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Framework for the evaluation of new tests for tuberculosis infection Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020 Year: 2021 Are TB services in England adhering to new NICE guidelines on screening for latent TB? Source: International Congress 2017 – Migrants and screening Year: 2017 Tuberculosis: update on new diagnostic methods and treatment approach Source: Annual Congress 2007 - Infections year in review Year: 2007 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Universal HIV testing in London tuberculosis clinics: a cluster randomised controlled trial Source: Eur Respir J 2013; 41: 627-634 Year: 2013 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Evaluation of a tuberculosis control programme based on case-finding Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions Source: Eur Respir J 2002; 20: Suppl. 38, 368s Year: 2002 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015